Page 6,201«..1020..6,2006,2016,2026,203..6,2106,220..»

CVS/pharmacy and CVS Caremark Charitable Trust Continue to Support Communities Affected by Hurricane Sandy

Posted: Published on November 10th, 2012

WOONSOCKET, R.I., Nov. 9, 2012 /PRNewswire/ --As communities in New Jersey and New York continue to recover from Hurricane Sandy, CVS/pharmacy has re-opened nearly all of its stores in affected areas and is assisting with local disaster relief efforts. (Logo: http://photos.prnewswire.com/prnh/20100816/NE50800LOGO ) Access to Stores More than 1,200 CVS/pharmacy locations have reopened since the storm struck the East Coast and CVS is using generators in about 60 stores located in areas that are still experiencing power outages. Only 16 stores remain closed due to water or wind damage. In two of the hardest-hit areas in which CVS/pharmacy stores will remain closed for an extended period of time, the Company will operate mobile pharmacies at the sites of the closed stores in order to ensure that these communities will continue to have access to their prescribed medications. CVS/pharmacy is now operating a mobile pharmacy at the site of its closed store at 9301 Ventnor Avenue in Margate City, NJ. Next week, CVS/pharmacy will begin operating a second mobile pharmacy at the site of its closed store at 88-07 Rockaway Beach Boulevard in Rockaway Beach, NY. "CVS/pharmacy is committed to ensuring that the communities we serve have access to pharmacy services and … Continue reading

Posted in Pharmacy | Comments Off on CVS/pharmacy and CVS Caremark Charitable Trust Continue to Support Communities Affected by Hurricane Sandy

Progress in FSHD Muscular Dystrophy Research Hailed at International Meeting

Posted: Published on November 9th, 2012

Recent scientific breakthroughs are offering real hope for patients living with one of the most common forms of muscular dystrophy. Scientists from around the world converged on San Francisco for the FSH Society's International Research Consortium meeting to share the latest advances in facioscapulohumeral muscular dystrophy (FSHD) research, including a new genetic explanation for the muscle-wasting disease. San Francisco, CA (PRWEB) November 08, 2012 Thanks to the efforts of Perez and many other patients, FSHD research has come a long way. The evidence was there for all to see at the FSH Societys 2012 International Research Consortium & Research Planning Meeting, held on November 6, 2012, in conjunction with the annual meeting of the American Society of Human Genetics in San Francisco, CA. The biggest buzz at the meeting was generated by the discovery of a new gene for FSHD by scientists from the U.S., Netherlands and France. The study by Richard Lemmers and colleagues will be published in Nature Genetics on November 11. Over 90 percent of FSHD patients have a shortening of the D4Z4 region on chromosome 4, which results in the expression of a gene called DUX4, with apparent toxic effects in muscle. The newly found gene … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Progress in FSHD Muscular Dystrophy Research Hailed at International Meeting

Cedars-Sinai research: Preclinical muscular dystrophy data shows promise

Posted: Published on November 9th, 2012

Public release date: 7-Nov-2012 [ | E-mail | Share ] Contact: Sally Stewart Sally.stewart@cshs.org 310-248-6566 Cedars-Sinai Medical Center LOS ANGELES Nov. 7, 2012 Cedars-Sinai Heart Institute researchers have found that an experimental compound may help stem the debilitating effects of muscular dystrophy by restoring normal blood flow to muscles affected by the genetic disorder. The researchers studied HCT 1026, a new type of molecule in which nitric oxide is chemically attached to a standard anti-inflammatory agent, in a preclinical model of muscular dystrophy. Results suggest HCT 1026 may be beneficial for the treatment of Duchenne muscular dystrophy, which begins in early childhood, and Becker muscular dystrophy, which often occurs later in adulthood. Preliminary results were presented in April 2012 at the experimental Biology meeting and now the full study is published in the Public Library of Science (PLOS ONE) and is available online. Both forms of muscular dystrophy are caused by problems with a protein called dystrophin, which helps maintain healthy muscles. If patients have less dystrophin protein or if their body manufactures dystrophin protein that does not function correctly, their muscles cannot work properly and eventually become permanently damaged. As diseased muscles weaken over time, patients gradually can lose … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Cedars-Sinai research: Preclinical muscular dystrophy data shows promise

Preclinical muscular dystrophy data shows promise

Posted: Published on November 9th, 2012

ScienceDaily (Nov. 7, 2012) Cedars-Sinai Heart Institute researchers have found that an experimental compound may help stem the debilitating effects of muscular dystrophy by restoring normal blood flow to muscles affected by the genetic disorder. The researchers studied HCT 1026, a new type of molecule in which nitric oxide is chemically attached to a standard anti-inflammatory agent, in a preclinical model of muscular dystrophy. Results suggest HCT 1026 may be beneficial for the treatment of Duchenne muscular dystrophy, which begins in early childhood, and Becker muscular dystrophy, which often occurs later in adulthood. Preliminary results were presented in April 2012 at the experimental Biology meeting and now the full study is published in PLoSONE and is available online. Both forms of muscular dystrophy are caused by problems with a protein called dystrophin, which helps maintain healthy muscles. If patients have less dystrophin protein or if their body manufactures dystrophin protein that does not function correctly, their muscles cannot work properly and eventually become permanently damaged. As diseased muscles weaken over time, patients gradually can lose their ability to walk, sit or use their muscles in other ways. There is no cure now for either form of the disease. "There is … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Preclinical muscular dystrophy data shows promise

Earlier Treatment Greatly Benefits Children With Autism

Posted: Published on November 9th, 2012

November 7, 2012 Connie K. Ho for redOrbit.com Your Universe Online Researchers from Yale School of Medicine recently discovered that, when provided earlier treatment, children with autism spectrum disorders (ASD) showed serious improvements in behavior, communication and brain function. Dr. Fred Volkmar, Kevin A. Pelphrey, and other researchers at the Yale Child Study Center published the study on early treatment, paving a way for brain change in autistic children. The findings were discussed in a recent issue of the Journal of Autism and Developmental Disorders. The brain systems related to social perception had positive reaction to the pivotal response treatment, a kind of early intervention behavioral program that was developed at the University of California, Santa Barbara. Along with parent training, the treatment included a section just focused on play and includes areas for learning and development. ASD is a heterogeneous disorder, and research aimed at understanding treatment must address this heterogeneity, noted Pelphrey in the statement. Both the children in our current study made progress, but their degree of progress and level of skills at the end of treatment were distinct. Researchers explained how pivotal response treatment could help children as young as two years of age. In the … Continue reading

Comments Off on Earlier Treatment Greatly Benefits Children With Autism

New Study: Early Treatment Helps Autism

Posted: Published on November 9th, 2012

By Rick Nauert PhD Senior News Editor Reviewed by John M. Grohol, Psy.D. on November 7, 2012 Emerging research suggests early treatment for children with autism spectrum disorders (ASD) can significantly improve behavior, stimulate communication and enhance brain function. Yale School of Medicine researchers have published their study findings in the Journal of Autism and Developmental Disorders. Researchers Fred Volkmar, M.D., Kevin A. Pelphrey, Ph.D.,and colleagues say the study findings suggest that brain systems supporting social perception can be improved when an early intervention behavioral program is administered. In the study, investigators used a technique called pivotal response treatment. This treatment includes parent training, and employs play in its methods. ASDs are complex neurobiological disorders that inhibit a persons ability to communicate and develop social relationships, and are often accompanied by behavioral challenges. Until recently, the diagnosis of autism diagnosis typically was not confirmed until a child was about three to five years-old. As a result, treatment programs were developed for this older age group. Today, Volkmar and his team are diagnosing children as young as age one. The combination of an early diagnosis and then application of the pivotal response treatment intervention has been revealing. Pivotal response treatment, developed … Continue reading

Comments Off on New Study: Early Treatment Helps Autism

Find puts treatment for autism closer

Posted: Published on November 9th, 2012

Scientists at Auckland University's Centre for Brain Research say they have gained new understandings of the causes of autism, opening up new avenues for possible treatment. The ground-breaking research, done in collaboration with Stanford University in the United States, looked at brain cell communication and genetic mutations in people with autism. The team discovered that autism was caused by mutated brain proteins, called Shank3, weakening communication between brain cells. Head researcher Jo Montgomery said that the discovery was exciting because it meant treatments could be investigated. "Brain cells are incredibly sociable cells in the brain and they talk to each other all the time," she said. "There are about 10 trillion brain cells connected by about 10 billion synapses which gives you an idea of how much chatter is going on in your brain at one time, and all that chatter underlies how you see things, how you move, how you learn and how you remember things. "What we showed is that when you have these autism-associated mutations, this changes how synapses in the brain function." Dr Montgomery said there was definitely reason to get excited about the possibilities for a cure for autism, at some stage in the future. … Continue reading

Comments Off on Find puts treatment for autism closer

Kaplan Headache Center and the Stroke Treatment

Posted: Published on November 9th, 2012

Kaplan Headache Center and the Stroke Treatment Prevention Center - Clifton Park, NY Kaplan Headache Center and the Stroke Treatment Prevention Center 518-388-9900 http://www.yellowbook.com eugene-kaplan-md-erpxg8zma-5183889900.flvFrom:yellowbookViews:0 0ratingsTime:00:36More inHowto Style Link: Kaplan Headache Center and the Stroke Treatment … Continue reading

Comments Off on Kaplan Headache Center and the Stroke Treatment

RELY-ABLE®: Unprecedented long-term data support safety profile and sustained efficacy of PRADAX® for stroke …

Posted: Published on November 9th, 2012

Presented at AHA's Scientific Sessions 2012, first long-term results from the RELY-ABLE study demonstrate that advantages of PRADAX (dabigatran etexilate) treatment are maintained over more than four years PRADAX is the first and only novel oral anticoagulant supported by long-term clinical data Sustained benefits for both doses allow for persistent brain protection and tailored treatment according to patient needs BURLINGTON, ON, Nov. 8, 2012 /CNW/ - Data from the *RELY-ABLE study have provided additional data to support the long-term safety profile and efficacy of PRADAX (dabigatran etexilate) for stroke prevention in patients with non-valvular atrial fibrillation (AF). **1 The new long-term results presented at the American Heart Association's (AHA) Scientific Sessions, are highly consistent with the findings from the landmark RE-LY trial, the basis for the approval of PRADAX in countries all over the world. The rates of stroke and hemorrhage observed during the 2.3 years of blinded follow-up in RELY-ABLE correspond to the initial RE-LY results, supporting the benefit of both doses of PRADAX for tailored brain protection.1-3 The combined data from RE-LY and RELY-ABLE equates to over four years of experience and provides the most comprehensive evaluation of the benefits and safety of any novel oral anticoagulant for … Continue reading

Comments Off on RELY-ABLE®: Unprecedented long-term data support safety profile and sustained efficacy of PRADAX® for stroke …

Radisphere Helps Bring New Imaging Procedure to California’s Adventist Medical Center – Hanford to Aid in Stroke …

Posted: Published on November 9th, 2012

CLEVELAND--(BUSINESS WIRE)-- Radisphere (www.radispheregroup.com), the largest and fastest-growing national radiology group in the United States, today announced that it has helped implement a new imaging procedure for the medical staff at Adventist Medical Center - Hanford in California. The procedure, known as a computed tomography (CT) brain perfusion exam, can provide better diagnostic information for suspected stroke patients. Sanjeev Athale, M.D., who is the Onsite Medical Director of Radiology at Adventist Medical Center - Hanford and employed locally by Radisphere, was instrumental in bringing this new procedure to Adventist Health / Central Valley Network. We are excited to have this procedure, usually only offered at hospitals in major urban settings, available in the Central Valley, said Kendall Fults, R.N. and Senior Vice President of Network Operations at Adventist Health. It is important to have strategic partners like Radisphere to help us provide quality services so the medical staff can offer faster comprehensive patient care. A CT brain perfusion exam can quickly evaluate blood flow in the brain and help physicians see if a patient is about to have a stroke. The exam measures blood flow, blood volume, and the time required for blood to pass through tissue in order to … Continue reading

Comments Off on Radisphere Helps Bring New Imaging Procedure to California’s Adventist Medical Center – Hanford to Aid in Stroke …

Page 6,201«..1020..6,2006,2016,2026,203..6,2106,220..»